The early apoptotic events induced by environmental pollutants with carcinogenic properties are poorly understood. Here, we focus on the early cytotoxic effects of benzo [a] We show that while glycogen synthase kinase 3 beta (GSK3b) regulated the expression of HKII at the transcriptional level, glycogen synthase kinase 3 alpha (GSK3a) was involved in B[a]P-induced apoptosis via a decrease in c-Myc expression. The reduced level of c-Myc caused the relocation of HKII from the mitochondria to the cytosol, thereby being involved in the formation of reactive oxygen species and apoptosis.
Introduction
Polycyclic aromatic hydrocarbons (PAHs) such as benzo [a] pyrene (B[a]P) are major environmental contaminants, found in ambient air, cigarette smoke and smoked food. B[a]P exhibits carcinogenic effects, due to its metabolism by cytochrome P450 into reactive molecules which may form DNA adducts (Zedeck, 1980) . Such a genotoxic action along with non-genotoxic effects of B[a]P may be important for the final outcome: cell survival and possible mutations, or apoptosis (Huc et al., 2006; Salas and Burchiel, 1998; Solhaug et al., 2004) . Thus, a better characterization of the early non-genotoxic events induced by B[a]P may add important knowledge to the understanding of the mechanisms of mutagenesis or cytotoxicity. In our previous works, we showed that following B[a]P treatment, rat epithelial F258 cells underwent intrinsic apoptosis via a translocation of hexokinase II (HKII) from mitochondria to cytosol and/or reduction of HKII mRNA levels, both events being prevented by p53 or Na + /H + exchanger isoform 1 (NHE1) silencing (Huc et al., 2006 (Huc et al., , 2007 . Since HKII dysfunction regulates B[a]P-induced apoptosis in F258 cells but may also alter cell energy metabolism, this event may represent an important B[a]P-related carcinogenic issue; thus in the present study, we aimed at deciphering the mechanisms underlying HKII dysfunction upon B[a]P exposure. HKII is a glycolytic enzyme that mediates the phosphorylation of glucose, and couples intra-mitochondrial ATP synthesis to glucose metabolism. HKII favors aerobic glycolysis, cell proliferation and the maintenance of a low level of reactive oxygen species (Ahn et al., 2009) . HKII has been shown to be over-expressed in highly malignant tumors (Mathupala et al., 2001; Peng et al., 2008) ; and its translocation from mitochondria has been suggested to play a role in cell death (Pastorino and Hoek, 2003; Plas et al., 2002) . Glycogen synthase kinase 3 (GSK3) has been reported to be involved in HKII translocation during the mitochondrial apoptotic pathway (Pastorino et al., 2005 GSK3a and GSK3b are serine/threonine kinases with enzymatic activity regulated by many signaling pathways (Ding et al., 2000; Kim and Kimmel, 2000) . The two GSK3 isoforms are not redundant; indeed, only GSK3b deficiency is lethal in embryogenesis (Hoeflich et al., 2000) . Thus GSK3 isoforms have different functions depending on cell models and/or the physiological pathway involved (Beurel and Jope, 2006; Markou et al., 2008) . GSK3 is involved in multiple cellular processes, including metabolism, proliferation, and cell differentiation (Frame and Cohen, 2001) . Recent studies identify GSK3 as a regulator of the balance between survival and apoptosis (Hernandez-Davies et al., 2011; Spokoini et al., 2010) . GSK3 can elicit pro-apoptotic effects by regulating anti-apoptotic transcription factors (b-catenin, HSF-1, Myc) or proteins involved in mitochondria function (p53, CREB) (Bijur et al., 2000; Ciani and Salinas, 2005) .
The present study aimed at looking for the possible involvement of GSK3 in B[a]P-induced apoptosis. Our data identified GSK3, and more precisely GSK3a, as a regulator of c-Myc expression which controls B[a]P-induced mitochondrial dysfunction via HKII, thus leading to apoptosis.
Materials and methods

Chemicals and antibodies
Benzo[a]pyrene (B[a]P), lithium chloride (LiCl), a-naphthoflavone (a-NF) and DEVD-AMC (Asp-Glu-Asp-7-amino-4-methylcoumarin) were purchased from Sigma Chemicals Co (St Louis, MO, USA). Peptidic inhibitor of GSK3 (IGSK) was purchased from Calbiochem (France Biochem, Meudon, France). All these products were used as a stock solution in dimethyl sulfoxide; final concentration of this vehicle in culture medium was <0.05% (v/v) ; control cultures received the same concentration of vehicle as treated cultures. Hoechst 33342 and mouse monoclonal Cytochrome C Oxidase 4 (COX IV) antibody were purchased from Invitrogen (Invitrogen, France). Rabbit polyclonal anti-c-Myc, goat polyclonal anti-hexokinase II and mouse monoclonal anti-b-actin were from Santa Cruz Biotechnology (Tebu-bio SA, Le Perray en Yvelynes, France). Rabbit polyclonal anti-GSK3a, anti-GSK3a phospho Serine 21, anti-GSK3b, and anti-GSK3b phospho Serine 9 antibodies were purchased from Cell Signaling (Ozyme, St Quentin-en-Yvelynes, France). Secondary antibodies conjugated to horseradish peroxidase were from Dako A/S (Glostrup, Denmark).
Cell culture, apoptosis measurement and Western blotting immunoassays
The F258 rat liver epithelial cell line was cultured in Williams'E medium supplemented with 10% fetal calf serum, 2 mM L-glutamine, 5 IU/ml penicillin, and 0.5 mg/ml streptomycin at 37°C under a 5% CO 2 atmosphere and treated 24 h following seeding as previously described (Huc et al., 2004) . Microscopical detection of apoptosis was performed in both floating and adherent cells, using Hoechst 33342 labeling, as previously described (Huc et al., 2004) . Caspase 3/7 activity assay has been previously described (Huc et al., 2004) . Western blot analysis was performed as previously described (Huc et al., 2006) .
Transfection of small interfering RNAs (Si RNA)
The following Si RNAs were used: Si RNA oligonucleotides directed against GSK3a (Si Genome SMART pool, NM_080107_00); GSK3b (Si Genome SMART pool, NM_080108_00); Si RNA negative control (Si Neg, Si control non-targeting Si RNA#1) (all from Thermo scientific Dharmacon, Colorado); Si RNA against c-Myc (SASI Rn01_00089127, SASI Rn01_00089127_AS) (Sigma Aldrich, France). Transfections of Si RNA were performed in 60-mm dishes on 90% confluent F258 cells; per dish, Si RNA (100 nM) and 12.5 ll TransFectin lipid reagent were applied in a final volume of 2 ml Opti-MEM for 4 h. Transfection rate was evaluated with Si Fluo and corresponds to 86 ± 5% (n = 4) transfected cells. Transfected cells were seeded in order to be treated the day after with B[a]P (5 lM). Previous analysis showed that F258 cells exposure to B[a]P 5 lM during 36 h, underwent the same apoptotic events as cells exposed to B[a]P 50 nM, during 72 h (Huc et al., 2004; Tekpli et al., 2010) . Thus, to keep a good rate of protein down-regulation when transfection with Si RNA was applied, cells were exposed to B[a]P 5 lM during 36 h.
Transfection of plasmids
Transfection of vector pExpress-1 with c-Myc gene (Rat MGC Verified FLcDNA, MRN1768_98079299) (ThermoScientific Open Biosystems, France) was performed according to manufacturer's recommendations. pExpress-1 plasmid control was purchased from Express Genomics (Express Genomics, Maryland/USA). Transfections of plasmids were performed in 60-mm dishes on 90% confluent 
RNA isolation and analysis
Total RNA extraction and reverse transcription-real time quantitative polymerase chain reaction (RT-PCR) were carried as previously described (Tekpli et al., 2010) . The specificity of each gene amplification was checked at the end of PCR reactions through the analysis of dissociation curves of the PCR products. The amount of target cDNA in each sample was established by determining a fractional PCR threshold cycle number (Ct). The expression levels of target genes were normalized to the expression of the 18S gene. The sequences of the primers used for RT-PCR analysis were as follows: 18S sense: GGAAGCATTTGCCAAGAAT and antisense: AGTCGGCATCGTTTATGGTC; Hexokinase II sense: CAACATCGT-CACTGCCATCT and antisense: GGGACCACTTGCTTCCATTA.
Mitochondrial fractionation
Mitochondrial fractionation was carried as previously described (Huc et al., 2007) .
Statistical analysis
All data are quoted as mean ± standard error of mean along with number of observations, n, corresponding to separate cultures. AN-OVA followed by a Student-Newman-Keuls post-test was used to compare means. In cases of non-normal distributions, ANOVA followed by Dunn post-test was used to compare medians. p < 0.05 was considered statistically significant.
Results
GSK3 is involved in B[a]P-induced apoptosis
Our first set of experiments was carried out to determine a possible implication of GSK3 in B[a]P-induced apoptosis. F258 cells were pre-treated 1 h with two different inhibitors of GSK3, i.e. a peptidic inhibitor (IGSK) and lithium chloride (LiCl) (Feyt et al., 2005) , and subsequently co-treated 72 h with B[a]P (50 nM). Analysis of cells with apoptotic morphology (condensed or fragmented nuclei), and measurement of caspase 3/7 activity demonstrated that both inhibitors reduced B[a]P-induced apoptosis ( Fig. 1A and  B) . The two concentrations of LiCl tested gave similar results; further experiments were thus carried out with the lowest concentration. Small interference RNA directed against both GSK3 isoforms (Si GSK3a/b) efficiently reduced the protein expression of GSK3 isoforms compared to Si negative controls (Si Neg) (Fig. 1C) , and significantly decreased B[a]P-induced apoptosis determined by fluorescence microscopy and caspase 3/7 activities ( Fig. 1D and  E) . Note also that, whereas no changes in the phosphorylation state of Ser 9 in GSK3b was observed, B[a]P induced a phosphorylation of GSK3a at Ser 21 (Fig. 1C) .
GSK3a rather than GSK3b is involved in B[a]P-induced apoptosis
Si RNAs targeting either GSK3 isoform were next tested on B[a]P-induced apoptosis. Even though the Si RNAs directed against GSK3b (Si GSK3b) were efficient regarding the silencing of this isoform ( Fig. 2A) , they had no effect on B[a]P-induced apoptosis ( Fig. 2B and C) . In contrast, regarding the Si RNAs directed against GSK3a, besides specific reduction of the protein expression (Fig. 2D) , they also significantly reduced the apoptotic effects of B[a]P (Fig 2E and F) .
GSK3 regulates HKII expression and localization
We next investigated a possible role for GSK3 in B[a]P-induced down-regulation of HKII mRNA expression (Huc et al., 2007) . Quantitative RT-PCR and SYBR green method showed that GSK3 anti -GSK3a, -P-GSK3a (Ser 21), -GSK3b, -P-GSK3b (Ser 9), and mouse monoclonal anti-b-actin antibodies.
inhibitors as well as Si GSK3a/b and Si GSK3b prevented the B[a]P-induced reduction of HKII mRNA expression (Fig. 3A and  B) . In order to gain further insight into the involvement of GSK3 in B[a]P-induced apoptosis, we tested the role of GSK3 in the control of mitochondrial HKII localization. After a 72 h-treatment with 50 nM B[a]P, HKII was released from mitochondria into cytosol (Huc et al., 2007) , as shown by the decrease in the mitochondrial expression of HKII (Fig. 3C) or by the loss of co-staining of HKII with the specific mitochondrial fluoroprobe mitotracker (red) (Supplementary Fig. 1 ). GSK3 inhibitors prevented from B[a]P-induced HKII relocation from the mitochondria (Fig. 3C , Supplementary Fig. 1) . GSK3 inhibitors or Si RNA directed against both GSK3 isoforms also prevented from the consequences of the mitochondrial dysfunction as estimated by the anion superoxide (O À 2 ) production ( Fig. 3D and Supplementary Fig. 2 ). Taken together, these results suggest that B[a]P, through a process involving GSK3, affects the mRNA expression of HKII and its protein sub-cellular localization.
GSK3a regulation of c-Myc expression is involved in apoptosis
The proto-oncogene c-Myc has been reported to be involved in the apoptosis mediated by GSK3 inhibition (Kotliarova et al., 2008) , and also to regulate the expression of HKII (Podar and Anderson, 2010) . Thus, as B[a]P might affect c-Myc expression (Fields et al., 2004; Zhao and Ramos, 1998) , we tested the possible involvement of c-Myc in the B[a]P-induced signaling cascade. We found that B[a]P markedly reduced the level of c-Myc protein. Such an effect was prevented by the cytochrome P450-inhibitor: a-naphthoflavone (a-NF) (Fig. 4A) . Interestingly, both LiCl and IGSK (Fig. 4A) as well as Si RNA directed against GSK3a (Fig. 4B) Supplementary Fig. 3 ).
To counteract the effects of B[a]P on c-Myc expression we transfected the cells with a c-Myc-plasmid construct. Over-expression of c-Myc using a plasmid construct (Pl c-Myc), significantly decreased B[a]P-induced apoptosis compared to cells transfected with a control plasmid (Pl Ctr) (Fig. 4C) . Furthermore, c-Myc over-expression inhibited the B[a]P-induced reduction of mitochondrial HKII protein level (Fig. 4D) . In contrast, silencing of c-Myc expression using Si RNA directed against c-Myc (Si c-Myc) significantly enhanced apoptosis (Fig. 4E) .
Therefore, in B[a]P-treated cells, the c-Myc decrease controlled by GSK3a appears to play a significant role in the related apoptosis, and might constitute the intermediate between GSK3a and HKII, since c-Myc expression regulated the mitochondrial HKII protein levels.
Discussion
Our previous works demonstrated the prominent role of translocation of HKII from mitochondria to cytosol in B[a]P-induced apoptosis in F258 cells; p53 and NHE1 activations cross-talked to deregulate HKII mitochondrial localization as well as its mRNA expression (Huc et al., 2007) . The present study identifies for the first time the couple GSK3a/c-Myc as a novel target in B[a]P-induced apoptosis (Fig. 5) .
Most of the studies regarding the role of GSK3 in apoptosis have reported that the b isoform is preferentially involved in the apoptotic cascade, notably by inducing a mitochondrial dysfunction (Pastorino et al., 2005; Vene et al., 2008) . The experiments carried out with Si RNA targeting either isoform pointed to GSK3a as being the major isoform involved in our apoptotic model. Most of the studies linking GSK3 to HKII translocation have shown an involvement of the b isoform (Das et al., 2008; Pastorino et al., 2005) . In this context, our study is the first one to clearly evidence a role for GSK3a in the control of HKII sub-cellular localization. The apoptotic role of GSK3a has also been reported by others, notably in cardiac cells (Zhai et al., 2007) ; thus, a link between GSK3a and HKII would deserve more focus in the future.
Our previous work demonstrated that B[a]P down-regulates the mRNA expression of HKII in F258 cells. The present study shed some light on the underlying intracellular mechanism since GSK3b seems to be involved in this regulation. But GSK3b appears not to be involved in B[a]P-induced apoptosis; this might thus indicate that the decrease in HKII mRNA expression would not be essential for apoptosis to occur whereas the GSK3a-dependent HKII translocation might be the main key event responsible for the mitochondrial dysfunction induced by B[a]P. Nevertheless, it is worth noting that a recent study in mice showed that in vivo down-regulation of HKII expression might constitute an efficient therapeutic strategy towards colon cancer development (Peng et al., 2008) . It would be interesting to test the consequence of HKII mRNA expression down-regulation on mitochondrial HKII protein level in this latter model.
The present work further illustrates the differential roles for the two GSK3 isoforms. Indeed, it has been shown for example that GSK3a KO mice develop normally whereas targeted deletion of GSK3b leads to embryonic lethality (Force and Woodgett, 2009 ); moreover, whereas Ser 9 phosphorylation of GSK3b mediates pathological cardiac hypertrophy, Ser 21 phosphorylation of GSK3a would play a compensatory role during pressure overload (Matsuda et al., 2008) . Regarding the present study, we found that B[a]P decreased cMyc expression; this was prevented by inhibition of GSK3. Furthermore, c-Myc was found to be involved in apoptosis via the control of HKII mitochondrial localization. Our data therefore suggest a link between GSK3a, c-Myc and HKII. c-Myc is known to be involved in the regulation of glucose metabolism (Dang et al., 2009; Valera et al., 1995) ; one might then suppose that the decrease in c-Myc expression may lead to a decrease in intracellular glucose, thereby favoring the disruption of HKII from mitochondria.
It remains to be determined if the decrease of c-Myc expression is involved in the regulation of HKII mRNA expression by GSK3b. In support to this hypothesis, it has been shown that c-Myc can transactivate the HKII gene (Kim et al., 2007) . When considering the regulation of c-Myc expression by GSK3, it is worth noting that it has been shown that GSK3 is capable of binding c-Myc in nucleus, which would allow the Thr-58 phosphorylation of c-Myc and hence regulation of its stability (Gregory et al., 2003) . Finally, a very recent study has evidenced, by using statins, that the enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA reductase) might be a critical regulator of c-Myc phosphorylation, activation, and tumorigenic properties, since an inhibition of HMG-CoA reductase blocked the phosphorylation and activation of c-Myc (Cao et al., 2011) . As B[a]P has been previously shown to inhibit this enzyme in our apoptosis model (Tekpli et al., 2010) , such a link between HMG-CoA reductase and c-Myc expression would deserve further investigation.
In conclusion, the present study evidences a new role for GSK3a in B[a]P-induced cell death via changes in c-Myc level and HKII sub-cellular localization. As HKII is over-expressed in various types of cancer cells (Mathupala et al., 2001; Peng et al., 2008) , our study might help identifying new anticancer therapeutic targets to modulate HKII tumor effects. Finally, our data provide new information regarding the signaling pathways induced by B[a]P which regulate the delicate balance between proliferation, cell cycle arrest, cell survival and apoptosis.
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